Photochemical Synthesis of Pyrazolines from Tetrazoles in Flow
SynOpen · 01.02.2023 · 07 (01) · 69-75
DOI: 10.1055/a-1995-1859 ↗Kurz gefasst
Fachartikel in der Zeitschrift SynOpen, erschienen am 01.02.2023. Verfasst von Marcus Baumann und 3 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society of Chemistry, Science Foundation Ireland.
Abstract (Originalsprache)
Pyrazolines and their pyrazole congeners are important heterocyclic building blocks with numerous applications in the fine chemical industries. However, traditional routes towards these entities are based on multistep syntheses generating substantial amounts of chemical waste. Here we report an alternative approach using UV-light to convert tetrazoles into pyrazolines via a reagent-free photo-click strategy. This route generates nitrile imine dipoles in situ that are trapped with different dipolarophiles rendering a selection of these heterocyclic targets in high chemical yields. A continuous flow method is ultimately realized that generates multigram quantities of product in a safe and readily scalable manner thus demonstrating the value of this photochemical approach for future exploitations in industry.
Förderung
- Royal Society of Chemistry
- Science Foundation Ireland
Zitieren
APA
Baumann, M., Burke, A., Spiccio, S., & Filippo, M. D. (2023). Photochemical Synthesis of Pyrazolines from Tetrazoles in Flow. SynOpen, 07(01), 69-75. https://doi.org/10.1055/a-1995-1859
Vancouver
Baumann M, Burke A, Spiccio S, Filippo MD. Photochemical Synthesis of Pyrazolines from Tetrazoles in Flow. SynOpen. 2023;07(01):69-75. doi:10.1055/a-1995-1859
BibTeX
@article{Baumann2023,
author = {Baumann, Marcus and Burke, Adam and Spiccio, Silvia and Filippo, Mara Di},
title = {Photochemical Synthesis of Pyrazolines from Tetrazoles in Flow},
journal = {SynOpen},
year = {2023},
volume = {07},
number = {01},
pages = {69--75},
doi = {10.1055/a-1995-1859}
}
EUVIMED